Scinai Immunotherapeutics Income Statement (2014-2025) | SCNI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Jun2025	Dec2025
Revenue & cost
Revenue (Quarter)																	0.17M	0.21M
Cost of Revenue (Quarter)																	0.42M	0.37M
Gross Profit (Quarter)																	-0.25M	-0.17M
Operating items
Research & Development (Quarter)	12.58M	7.87M	0.82M	1.90M	2.02M	-3.43M	1.16M	1.97M	1.19M	1.43M	2.00M	1.45M	-1.13M	0.63M	1.57M	-4.36M	1.41M	9.73M
Selling, General & Administrative (Quarter)	7.30M	4.26M	1.20M	7.00M	6.20M	-9.58M	1.45M	1.29M	0.97M	1.59M	1.19M	1.14M	-0.97M	7.80M	0.48M	-1.49M	-0.76M	4.29M
Other Operating Expenses (Quarter)	35.72M							7.52M						9.16M	-0.12M	0.12M	-2.81M
Operating Expenses (Quarter)	55.60M	12.13M	2.03M	8.90M	8.22M	-13.01M	2.62M	10.78M	2.16M	3.02M	3.19M	2.60M	-2.10M	17.59M	1.93M	-5.72M	-2.17M	14.02M
Operating Income (Quarter)	55.60M	-12.13M	-2.03M	-8.90M	-8.22M	13.02M	-2.62M	3.26M	2.16M	-19.10M	3.19M	2.60M	-2.10M	-1.82M	1.93M	-5.88M	-2.42M	-2.26M
EBIT (Quarter)	55.60M	-12.13M	-2.03M	-8.90M	-8.22M	13.02M	-2.62M	3.26M	2.16M	-19.10M	3.19M	2.60M	-2.10M	-1.82M	1.93M	-5.88M	-2.42M	-2.26M
Non-operating items
Interest & Investment Income (Quarter)													-5.21M				13.37M
Other Non Operating Income (Quarter)											0.33M	1.17M	-5.21M	-3.70M	0.23M	-0.76M	-1.88M	16.14M
Non Operating Income (Quarter)	0.28M	-0.41M	-0.30M	0.52M	-1.80M	1.20M	0.14M	-0.28M	-6.94M	12.62M	-0.33M	1.17M	-5.21M	6.92M
Net income details
EBT (Quarter)	55.89M	-11.36M	-1.24M	-5.81M	-5.42M	15.75M	-1.88M	6.91M	-0.39M	-19.10M	3.19M	2.60M	-7.31M	-1.82M	1.93M	-5.88M	10.95M	-2.26M
Profit After Tax (Quarter)	55.31M	-14.10M	-2.46M	-11.99M	-9.05M	21.02M	-2.48M	0.00M	-4.78M	-5.12M	3.52M	3.76M	-3.11M	-2.33M	2.16M	2.32M	10.95M	-2.26M
Investment Income (Quarter)													-3.11M				10.46M
Income from Continuing Operations (Quarter)	55.89M	-11.36M	-1.24M	-5.81M	-5.42M	15.75M	-1.88M	6.91M	-0.39M	-19.10M	3.19M	2.60M	-7.31M	-1.82M	1.93M	-5.88M	10.95M	-2.26M
Consolidated Net Income (Quarter)	55.89M	-11.36M	-1.24M	-5.81M	-5.42M	15.75M	-1.88M	6.91M	-0.39M	-19.10M	3.19M	2.60M	-7.31M	-1.82M	1.93M	-5.88M	10.95M	-2.26M
Income towards Parent Company (Quarter)	55.89M	-11.36M	-1.24M	-5.81M	-5.42M	15.75M	-1.88M	6.91M	-0.39M	-19.10M	3.19M	2.60M	-7.31M	-1.82M	1.93M	-5.88M	10.95M	-2.26M
Net Income towards Common Stockholders (Quarter)	55.89M	-11.36M	-1.24M	-5.81M	-5.42M	15.75M	-1.88M	6.91M	-0.39M	-19.10M	3.19M	2.60M	-7.31M	-1.82M	1.93M	-5.88M	10.95M	-2.26M
Additional items
EPS (Basic) (Quarter)	0.12	-0.03		-0.01	-0.01	0.03	0.00	0.69M		-0.03	0.00	0.43M		0.00		-2.94M		0.00
EPS (Weighted Average and Diluted) (Quarter)						0.03	0.00			-0.03	0.00			0.00		-2.94M		0.00
Shares Outstanding (Weighted Average) (Quarter)	461.05M	443.26M		573.21M	573.21M	564.58M	744.71M	10.00		754.08M	1,295.26M	6.00		1,562.63M		2.00		3,225.47M	1.00	9,339.46M
Shares Outstanding (Diluted Average) (Quarter)						564.58M	744.71M			754.08M	1,295.26M			1,562.63M		2.00		3,225.47M	1.00	9,339.46M
EBITDA (Quarter)	55.60M	-12.13M	-2.03M	-8.90M	-8.22M	13.02M	-2.62M	3.26M	2.16M	-19.10M	3.19M	2.60M	-2.10M	-1.82M	1.93M	-5.88M	-2.42M	-2.26M
Interest Expenses (Quarter)	-0.29M	-0.77M	-0.78M	-3.09M	-2.80M	-2.72M	-0.74M	-3.64M	2.56M

Research Tools

Developers

Scinai Immunotherapeutics Income Statement (2014-2025) | SCNI

Research Tools

Developers

Scinai Immunotherapeutics Income Statement (2014-2025) | SCNI

Create an account

Sign In

Reset Password